Apyx Medical CorporationAPYXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+22.3%
5Y CAGR-16.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+22.3%/yr
vs -39.4%/yr prior
5Y CAGR
-16.9%/yr
Recent acceleration
Acceleration
+61.7pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.94 | +123.6% |
| 2024 | 1.31 | -19.6% |
| 2023 | 1.63 | +1.9% |
| 2022 | 1.60 | -81.0% |
| 2021 | 8.44 | +14.1% |
| 2020 | 7.40 | -9.4% |
| 2019 | 8.17 | -31.3% |
| 2018 | 11.89 | +135.7% |
| 2017 | 5.05 | +11.2% |
| 2016 | 4.54 | - |